Merck KGaA

Merck KGaA, frequently referred to as "Merck" in many regions outside North America, is a German multinational science and technology company headquartered in Darmstadt. It is the world's oldest operating chemical and pharmaceutical company, tracing its origins to an apothecary shop founded in the 17th century. The company operates across three core business sectors: Healthcare, Life Science, and Electronics, developing everything from innovative cancer therapies to essential materials for semiconductor manufacturing.

History

The company's history began in 1668 when Friedrich Jacob Merck acquired the Engel-Apotheke (Angel Pharmacy) in Darmstadt. In 1827, Heinrich Emanuel Merck began the industrial-scale manufacturing of alkaloids, marking its transition from a pharmacy to a manufacturer. A significant split occurred following World War I, when the U.S. subsidiary was confiscated as alien property and became the independent Merck & Co., which operates separately today. Throughout the 20th century, the company expanded significantly, acquiring Serono in 2007 to bolster its biopharmaceutical presence and Sigma-Aldrich in 2015 to create a global leader in the life science industry.

Business segments

The company's operations are organized into three main sectors. The Healthcare sector focuses on prescription medicines, with leading products in areas like oncology and fertility. The Life Science sector provides a vast portfolio of products and services for scientific research, biopharmaceutical manufacturing, and testing, serving customers from academic labs to major biotech firms. The Electronics sector supplies high-tech materials crucial for the semiconductor and display industries, including materials for photolithography and OLED screens.

Corporate affairs

The company is structured as a Kommanditgesellschaft auf Aktien (KGaA), a German hybrid entity, with the Merck family holding approximately 70% of the capital shares through E. Merck KG. Its executive board is led by Belén Garijo, who became Chair and CEO in 2021. Its global headquarters remain at its historic site in Darmstadt, with major research and production facilities worldwide, including significant sites in the United States, Switzerland, and Ireland. The company is a constituent of the DAX index on the Frankfurt Stock Exchange.

Products and innovations

Notable products span its diverse portfolio. In healthcare, key innovations include Erbitux for treating certain cancers and Mavenclad for multiple sclerosis. The life science business is known for its Millipore filtration products and the SAFC supply chain for cell culture media. The electronics unit produces materials like Liquid crystals for LCDs and ultrapure chemicals for wafer processing. Historically, the company's scientists have made seminal contributions, such as the first synthesis of Morphine and the isolation of MDMA.

Environmental and social impact

The company has committed to ambitious sustainability goals, including achieving climate neutrality in its operations by 2040. It actively participates in global health initiatives, such as the Access to Medicine Index, and runs programs to improve healthcare in developing regions. Its corporate responsibility efforts also focus on fostering STEM education and promoting diversity within its global workforce, aligning with frameworks like the United Nations Global Compact.

Category:Companies listed on the Frankfurt Stock Exchange Category:Pharmaceutical companies of Germany Category:Companies based in Darmstadt Category:Chemical companies of Germany